PEPTIDE DATABASE

Exenatide

Byetta; Bydureon; Exendin-4 analog

A synthetic version of exendin-4 that activates the GLP-1 receptor and has been used clinically in type 2 diabetes.

GLP-1 receptor agonist Established clinical compound Approved prescription drug for specific indications

COMPOUND DATA

Molecular Information

Classification GLP-1 receptor agonist

Molecular Weight Not available

Molecular Formula Not available

Research Status Established clinical compound

BIOLOGICAL ATLAS

Systems Associated With Exenatide

Brain & CNS

Approved / Established

Established pharmacological pathway

GLP-1 receptor agonist extensively studied in glucose regulation and metabolic physiology.

Gastrointestinal

Approved / Established

Established pharmacological pathway

GLP-1 receptor agonist extensively studied in glucose regulation and metabolic physiology.

Pancreas & Glucose

Approved / Established

Established pharmacological pathway

GLP-1 receptor agonist extensively studied in glucose regulation and metabolic physiology.

Metabolic

Approved / Established

Established pharmacological pathway

GLP-1 receptor agonist extensively studied in glucose regulation and metabolic physiology.

Endocrine & Hormonal

Approved / Established

Established pharmacological pathway

GLP-1 receptor agonist extensively studied in glucose regulation and metabolic physiology.

STATUS

Regulatory Information

Approved prescription drug for specific indications

Regulatory status can vary by jurisdiction and may change over time.

HAXBIO COMMUNITY

Exenatide Discussions & News

No community posts yet Nothing about Exenatide has been posted yet.

HaxBio provides information for educational and research purposes. Information on this page should not be interpreted as medical advice.